Jobs / United States / Glaxosmithkline LLC
Marketing Manager - Oncology
Glaxosmithkline LLC · 🇺🇸 Finance Center Building
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: - Translate therapy area strategy into local oncology marketing plans with clear, measurable objectives. - Use customer and market insights to design patient and healthcare professional journeys. - Plan and deliver integrated multichannel campaigns, coordinating with local teams and external partners. - Work with medical, regulatory and sales teams to ensure compliant, effective execution in market. - Monitor campaign performance, analyse results and recommend improvements to increase impact and return. - Manage vendor relationships and budget for promotional activities and events. Why You? Work model This role is on-site in the Philippines with regular collaboration across functions and occasional travel to field and external meetings. Basic Qualification We are seeking professionals with the following required skills and qualifications to help us achieve our goals - Bachelor’s degree in business, life sciences, pharmacy, marketing or related field. - Minimum 3 years’ experience in pharmaceutical marketing, product management or brand management. - Experience planning and executing multichannel campaigns. - Strong commercial acumen and experience using insight to drive marketing plans. - Proven ability to work cross-functionally and influence stakeholders. - Knowledge of local regulatory and promotional standards in the Philippines. Preferred Qualification If you have the following characteristics, it would be a plus - Experience in oncology or specialty care marketing. - Experience working with private hospitals, specialty clinics, or institutional channels. - Familiarity with customer journey design and digital channel optimisation. - Experience developing training and sales enablement materials. - Strong analytical skills and comfort using data to guide decisions. - Demonstrated coaching or mentoring experience. What we value in you - Clear, direct communicator who listens and builds trust. - Practical problem solver who acts with integrity and accountability. - Learner who seeks feedback and shares knowledge. - Collaborative team member who supports inclusion and diverse perspectives. We want to hear from you. Apply now and tell us how your experience will help drive meaningful impact for patients and teams. Skills Data to Insights, Digital Fluency, Marketing Campaign Planning, Marketing Measurement, Marketing Strategy Implementation, Omnichannel Marketing, Scientific Literacy Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and